Table 2 Conventional treatment in CT + V and CT + I groups.

From: Increased survival in puppies affected by Canine Parvovirus type II using an immunomodulator as a therapeutic aid

Treatment classification CT + V CT + I
Fluid therapy 0.9% NaCl solution 7/7 0.9% NaCl solution 11/11
Antibiotics    Ampicilin 5/11
Ampicilin 3/7 Metronidazole 8/11
Metronidazole 5/7 Enrofloxacin 2/11
Enrofloxacin 2/7 Clindamicyn 1/11
Cephalexin 5/7 Sulfa-trimethoprim 4/11
Antiemetics Maropitant citatre 7/7 Maropitant citrate 9/11
Metoclopramide 4/7 Metoclopramide 5/11
Antiespasmodics Prifinial 1/7 Butylhioscine 5/11
Gastric mucosa protectors    Ranitidine 8/11
Ranitidine 4/7 Omeprazole 9/11
Omeprazole 7/7 Sucralfate 4/11
Analgesics    Buprenorphine 10/11
Buprenorphine 7/7 Lidocaine 5/11
Meloxicam 1/7 Metamizole 3/11
Others 0.5% Dextrose 5/7 0.5% Dextrose 8/11
Aminolyte 2/7
  1. Treatments were classified according to their action mechanism. The number of puppies that received each of the treatments is specified.
  2. CT conventional treatment, I immunomodulatory, V vehicle.